$ARNA, $GE, $MRVL, $MNST, $NKTR, $PG

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of The Street’s Key analysts outlook for Key issues for Friday as follows:

Arena Pharmaceutical Inc. (NASDAQ:ARNA) was started with Buy rating at Berenberg with a 55 price target, and that compares with a Wall Street consensus target at 62.78.

General Electric Co. (NYSE:GE) was raised to Neutral from Underweight at JPMorgan with a 6 price target. The venerable industrial has been pounded this year, and the change is a boost for the company as the analyst has been a long-time Bear on the shares. The stock has traded between $6.66 and 19.39 over the past year. The consensus price target is 12.83.

Marvell Ltd. (NASDAQ: MRVL) was raised to Buy from Neutral at Citigroup. The 52-wk trading range for the stock is 14.69 – 25.18, and the consensus price target is 23.72. 

Monster Beverage Corp. (NASDAQ:MNST) was started with a Sell rating at UBS, which has a 48 price target. That figure compares with a consensus price target of 62.71.

Nektar Therapeutics Inc. (NASDAQ:NKTR) was started with a Buy rating at Goldman Sachs, which has a price target of 62. That is in comparison to a massive consensus target of 81. 

Procter & Gamble Co. (NYSE:PG) was raised to Buy from Neutral at Merrill Lynch. The 52-wk trading range for the consumer goods giant is 70.73 – 94.86. The consensus price target is at 89.47. The shares closed Thursday at 96.49.

Have a terrific weekend.

  analysts, ARNA, buy, GE, heffx, market, MNST, MRVL, NKTR, outlook, PG, report, research, save, sell

The following two tabs change content below.

• Bio
• Latest Posts

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

• Wall Street’s Key Stock Analysts Research Report, All Buys - March 30, 2020
• Commentary: Paul Ebeling on Wall Street, World Vs Coronavirus - March 30, 2020
• Gold: Conditions Setting Up for the Price to 2X - March 30, 2020